Abstract
Epidemiological studies suggest that around one-third of all human cancers are related to the diet (Doll and Peto, 1981). Many studies on the presence of natural mutagens, antimutagens and cancer-modulating compounds as inherent factors of our food have been published in the last decade (Ahmed, 1992; Norred and Voss, 1994). At one time it was the opinion in cancer research that there was no relationship between carcinogens and mutagens, but reports that 4-nitroquinoline-N-oxide (4NQO), a carcinogen, also had the property of inducing spontaneous mutation in bacteria, and that N-methyl-N’-nitro-nitrosoguanidine (MNNG), a known mutagen, also induced stomach cancer, led inexorably to the conclusion that there is a close relationship between the two, and today it is clear that 85% of carcinogens are mutagenic (Sugimura, 1982). This indicates that there may be a steady increase in substances combining mutagenicity and carcinogenicity in our surroundings.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abe, N, Yamaguchi, T., Hoshino, F. et al. (1982) Antitumor and interferon-inducing activities of TH69, whole bacterial preparation of Streptococcus faecalis, in mice. Gann, 73, 811–818.
Adachi, S. (1992) Lactic acid bacteria and the control of tumours in the lactic acid bacteria, in The Lactic Acid Bacteria in Health and Disease., Vol. 1 (ed. B. J. B. Wood), Elsevier Applied Science, London, pp. 233–261.
Ahmed, F. E. (1992) Effect of diet on cancer and its progression in humans. Environ. Carcinog. Ecotoxicol. Rev., C10, 141–180.
Asano, M., Karasawa, E. and Takayama, T. (1986) Antitumour activity of Lacto-bacillus casei (LC9018) against experimental mouse bladder tumour (MBT-2). J. Urology, 136, 719–721.
Ayebo, A. D., Shahani, K. M. and Dam, R. (1981) Antitumour component(s) of yogurt: fractionation. J. Dairy Sci., 64, 2318–2323.
Ayebo, A. D., Shahani, K. M., Dam, R. and Friend, B. A. (1982) Ion exchange separation of the antitumour component(s) of yogurt dialysate. J. Dairy Sci., 65, 2388–2390.
Ballongue, J. (1993) Bifidobacteria and probiotic action, in Lactic Acid Bacteria (ed. S. Salminen and A. von Wright), Marcel Dekker, New York, pp. 357–428.
Bodana, A. R. and Rao, D. R. (1990) Antimutagenic activity of milk fermented by Streptococcus thermophilus and Lactobacillus bulgaricus. J. Dairy Sci., 73, 3379–3384.
Bogdanov, I. (1982) Observation on the therapeutic effect of the anti-cancer preparation from Lactobacillus bulgaricus ‘LB-51’ tested on 100 oncologic patients (ed. I. Bogdanov), Sofia Press, Sofia, pp. 127.
Bounous, G., Batist, G. and Gold, P. (1991) Whey proteins in cancer prevention. Cancer Lett., 57, 91–94.
Buck, L. M. and Gilliland, S. E. (1994) Comparisons of freshly isolated strains of Lactobadllus acidophillus of human intestinal origin for ability to assimilate cholesterol during growth. J. Dairy Sci., 77, 2925–2933.
Deeth, H.C. (1984) Yogurt and cultured products. Aust. J. Dairy Tech., 39, 111–113.
Doll, R. and Peto, R. (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl Cancer Inst., 66, 1191–1308.
Ebina, T. and Murata, K. (1992) Antitumour effect of PSK at a distant site: tumour-specific immunity and combination with other chemotherapeutic agents. Jpn. J. Cancer Res., 83, 775–782.
Ebina, T., Kohya, H., Yamaguchi, T. and Ishida, N. (1986) Antimetastatic effect of biological response modifiers in the ‘double grafted tumour system’. Jpn J. Cancer Res. (Gann), 77, 1034–1042.
Fernandes, C. E., Shahani, K. M. and Amer, M. A. (1987) Therapeutic role of dietary lactobacilli and lactobacilli fermented dairy products. FEMS Microbiol. Rev., 46, 343–356.
Friend, B. A. and Shahani, K. M. (1984) Antitumour properties of lactobacilli and dairy products fermented by lactobacilli. J. Food Pro., 47, 717–723.
Friend, B. A., Fermer, R. E. and Shahani., K. M. (1982) Effect of feeding and intraperitonial implantation of yogurt culture cells on Ehrlich ascites tumour. Milchwissenschafl, 37, 708–710.
Gibson, G. R. and Wang, Xin. (1994) Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J. Appl. Bad., 77, 412–420.
Gibson, G. R., Beatty, E. R., Wang, Xin and Cummings, J. H. (1995) Selective stimulation of Bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology, 108, 975–982.
Gilliland, S. E. (1989) Acidophilus milk: a review of potential health benefits to consumer. J. Dairy Sci., 72, 2483–2494.
Gilliland, S. E. (1990) Health and nutritional benefits from lactic acid bacteria. FEMS Microbiol. Rev., 87,175–188.
Gilliland, S. E. (1991) Properties of yoghurt, in Therapeutic Properties of Fermented Milks (ed. R. K. Robinson), Elsevier Applied Science, London, pp. 65–80.
Gilliland, S.E. and Speck, M. L. (1977) Antagonistic action of Lactobadllus acidophilus towards intestinal and food borne pathogens in associative culture. J. Food Prot., 40, 820–823.
Gilliland, S. E. and Walker, D. K. (1990) Factors to consider when selecting a culture of Lactobadllus acidophilus as a dietary adjunct to produce a hypocholesterolemic effect in humans. J. Dairy Sci., 73, 905–911.
Gilliland, S.E., Nelson, C. R. and Maxwell, C. (1985) Assimilation of cholesterol by Lactobadllus acidophilus. Appl. Environ. Microbiol., 49, 377–381.
Gurr, M.I. (1987) Nutritional aspects of fermented milk products. FEMS Microbiol. Rev., 64, 337–342.
Hamdan, I. T. and Mikolajicik, E. M. (1974) Acidolin: an antibiotic produced by Lactobadllus acidophilus. J. Antibiotics, 27, 631–636.
Harrison, V. C. and Peat, G. (1975) Serum cholesterol levels in rats fed milk fermented by Lactobadllus acidophilus. J. Food Sci., 47, 2078–2079.
Hashimoto, S., Nomoto, K., Matsuzaki, T. et al. (1984) Oxygen radical production by peritoneal macrophages and kupffer cells elicited with Lactobadllus casei. Infect. Immun., 44, 61–67.
Hashimoto, S., Seyama, Y., Yokokura, T. and Mutai, M. (1985) Cytotoxic factor production in kupffer cells elicited with Lactobadllus and Corynebacterium parvum. Cancer Immunol. Immunother., 20, 117–121.
Hashimoto, S., Nomoto, K., Nagaoka, M. and Yokokura, T. (1987) In vitro and in vivo release of cytostatic factors from Lactobadllus casei elicited peritoneal macrophages after stimulation with tumour cells and immunostimulants. Cancer Immunol. Immunother., 24, 1–7.
Hepner, G., Fried, R., Jeor, S. St. et al. (1979) Hypocholesterolemic effect of yogurt and milk. Am. J. Clin. Nutr., 32, 19–24.
Hosoda, M, Hashimoto, H., Morita, H. et al. (1992a) Antimutagenicity of milk cultured with lactic acid bacteria against N-methyl-N’-nitrosoguanidine. J. Dairy Sci., 75, 976–981.
Hosoda, M., Hashimoto, H., Morita, H., Chiba, M. and Hosono, A. (1992b) Studies on antimutagenic effect of milk cultured with lactic acid bacteria on the Trp-P2-induced mutagenicity to TA 98 strain of Salmonella typhimurium. J. Dairy Res., 59, 543–549.
Hosono, A. (1988) The role of lactic acid bacteria as a scavenger of N-nitroso compounds in the intestinal tract. Bull. Jpn Dairy Tech. Assoc, 38, 1–17.
Hosono, A. (1992) Diet and mutagenic toxicity, in Functions of Fermented Milk (ed. Y. Nakazawa and A. Hosono), Elsevier Applied Science, London, pp. 233–261.
Hosono, A. and Hisamatsu, S. (1995a) Binding of amino acid pyrolysates and aflatoxins to autoclaved cells of Enterococcus faecalis FK-23. Biosci. Biotech. Biochem., 59, 940–942.
Hosono, A. and Tono-Oka, T. (1995b) Binding of cholesterol with lactic acid bacterial cells. Milchwissenschaft, 50, 556–560.
Hosono, A., Kashina, T. and Kada, T. (1986) Antimutagenic properties of lactic acid-culture milk on chemical and fecal mutagens. J. Dairy Sci., 69, 2237–2242.
Hosono, A., Sagae, S. and Tokita, F. (1986) Desmutagenic effect of cultured milk on chemically induced mutagenesis in Escherichia coli B/r WP2 trphcr. Milchwissenschaft, 41, 142–145.
Hosono, A., Yoshimura, S. and Otani. H. (1987) Antimutagenic activity of cellular component of Streptococcus faecalis IFO 12965. Netherlands Milk and Dairy J., 41, 239–245.
Hosono, A. Yoshimura, S. and Otani, H. (1988) Desmutagenic property of cell walls of Streptococcus faecalis on the mutagenicities induced by amino acid pyrolysates. Milchwissenschaft, 43, 169–170.
Hosono, A., Shashikanth, K. N. and Otani, H. (1989) Antimutagenic activity of whole casein on the pepper induced mutagenicity of streptomycin-dependent strain SD 510 of Salmonella typhimurium TA 98. J. Dairy Res., 55, 435–442.
Hosono, A., Yamazaki, H. and Otani, H. (1989) Antimutagenicity of slimy substance separated from the culture of Brevibacterium lines. Jpn J. Zootech. Sci., 60, 679–685.
Hosono, A., Wardojo, R. and Otani, H. (1990) Inhibitory effects of lactic acid bacteria from fermented milk on the mutagenicities of volatile nitrosamines. Agr. Biol. Chem., 54, 1639–1643.
Hosono, A., Suzuki, M. and Otani, H. (1991) Superoxide dismutase activity in the crude cell extract from Streptococcus salivarius subsp. thermophilus 3535. Anim. Sci. Tech., 62, 39–44.
Kada, T., Inoue, T. and Namiki, M. (1981) Environmental desmutagens and antimutagens, in Environmental Mutagenesis, Carcinogenesis and Plant Biology, Vol. 1 (ed. E. J. Klekowski), Praeger, New York, pp. 133–151.
Kaklij, G. S., Kelkar, S.M. Shenoy, M. A. and Sainis, K. B. (1991) Antitumour activity of Streptococcus thermophilus against fibrosarcoma: role of T-cells. Cancer Lett., 56, 37–43.
Kanatani, K., Oshimura, M. and Sano, K. (1995) Isolation and characterization of acidocin A and cloning of the bacteriocin gene from Lactobacillus acidophilus. Appl. Environ. Microbiol., 61, 1061–1067.
Kato, I., Kobayashi, S., Yokokura, T. and Mutai, M. (1981) Antitumour activity of Lactobacillus casei in mice. Gann, 72, 517–523.
Kato, I., Yokokura, T. and Mutai, M. (1983) Macrophage activation by Lactobacillus casei in mice. Microbiol. Immunol, 27, 611–618.
Kato, I. Yokokura, T. and Mutai, M. (1984) Augmentation of mouse natural killer cell activity by Lactobacillus casei and its surface antigens. Microbiol. Immunol, 27, 209–217.
Kato, I., Yokokura, T. and Mutai, T. (1985) Induction of tumoricidal peritoneal exudate cells by administration of Lactobacillus casei. Int. J. Immunopharmac., 7, 103–109.
Kato, I., Yokokura. T. and Mutai, M. (1988) Correlation between increase in la-bearing macrophages and induction of T cell-dependent antitumour activity by Lactobacillus casei in mice. Cancer Immunol. Immunother., 26, 215–221.
Kato, I., Endo, K. and Yokokura, T. (1994) Effects of oral administration of Lactobacillus casei on antitumour responses induced by tumor resection in mice. Int. J. Immunopharmac, 16, 29–36.
Kelkar, S. M., Shenoy, M. S. and Kaklij, G. S. (1988) Antitumour activity of lactic acid bacteria on a solid fibrosarcoma, sarcoma-180 and Ehrlich ascites carcinoma. Cancer Lett., 42, 73–77.
Kimura, N. T., Yaniguchi, S., Aoki, K. and Baba, T. (1980) Selective localization and growth of Bifidobacterium bifidum in mouse tumours following intravenous administration. Cancer Res., 40, 2061–2068.
Kitazawa, H., Itoh, T. and Yamaguchi, T. (1991a) Induction of macrophage cytotoxicity by slime products produced by encapsulated Lactococcus lactis ssp. cremoris. Anim. Sci. Technol. (Jpn), 62 861–866.
Kitazawa, H., Nomura, M., Itoh, T. and Yamaguchi, T. (1991b) Functional alteration of macrophages by a slime-forming Lactococcus lactis ssp. cremoris. J. Dairy Sci, 74, 2082–2088.
Kitazawa, H., Toba, T., Itoh, T. et al. (1991c) Antitumoural activity of slime-forming, encapsulated Lactococcus lactis subsp. cremoris isolated from Scandinavian ropy sour milk, ‘villi’. Anim. Sci. Technol. (Jpn) 62, 277–283.
Kitazawa, H., Matsumura, K., Itoh, T. and Yamaguchi, T. (1992) Interferon induction in murine peritoneal macrophage by stimulation with Lactobacillus acidophilus. Microbiol. Immunol., 36, 311–315.
Kitazawa, H., Tomioka, Y., Matsumura, K. et al (1994) Expression of mRNA encoding IFN in macrophages stimulated with Lactobacillus gasseri. FEMS Microbiol. Lett., 120, 315–322.
Kiyosawa, I., Matsuyama, J. and Arai, C. (1992) Antimutagenicity of water and methanol extracts of soymilks fermented by Bifidobacteria and lactic acid bacteria. Nippon Shokuhin Kogyo Gakkaishi, 39, 939–944.
Klaenhammer, T.R. (1993) Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol. Rev., 12, 39–86.
Kohwi, Y., Hashimoto, Y. and Tamura, Z. (1982) Antitumour and immunological adjuvant effect of Bifidobacterium infantis in mice. Bifidobacteria Microflora, 1, 61–68.
Kohwi, Y., Imai, K., Tamura, Z. and Hashimoto, Y. (1978) Antitumour effect of Bifidobacterium infantis in mice. Gann, 69, 613–618.
Kuwabara, M., Kosaka, T., Tanaka, S. et al. (1988) Effect of Lactobacillus casei: formation of interferon and macrophage activating factor in mice in vivo. Jpn J. Vet. Sci., 50, 665–672.
Lichtenstein, A. K., Kahle, J., Berek, J. and Zighelbom, J. (1984) Successful immunotherapy with intraperitoneal Corynebacterium parvum in a murine ovarian cancer model is associated with the recruitment of tumour-lytic neutrophils into the peritoneal cavity. J. Immunol, 133, 519–526.
Lichtenstein, A. H. and Goldin, B. R. (1993) Lactic acid bacteria and intestinal drug and cholesterol, in Lactic Acid Bacteria (ed. S. Salminen and A. von Wright), Marcel Dekker, New York, pp. 227–235.
Mann, G. V. and Spoerry, A. (1974) Studies of a surfactant and cholesterolemia in the Massai. Am. J. Clin. Nutr., 27, 464–469.
Masuno, T., Kishimoto, S., Ogura, T. et al. (1991) A comparative trial of LC9018 plus Doxorubicin and Doxorubicin alone for the treatment of malignant pleural effusion secondary to lung cancer. Cancer, 68,1495–1500.
Matsumura, K., Kitazawa, H., Itoh, T. and Yamaguchi, T. (1992) Interferon induction by murine peritoneal macrophage stimulated with Lactobacillus gasseri. Anim. Sci. Technol. (Jpn), 63, 1157–1159.
Matsuzaki, T., Yokokura, T. and Azuma, I. (1985) Anti-tumour activity of Lactobacillus casei on Lewis lung carcinoma and line-10 hepatoma in syngeneic mice and guinea pigs. Cancer Immunol. Immunother., 20,18–22.
Matsuzaki, T., Yokokura, T. and Azuma, I. (1987) Antimetastatic effect of Lactobacillus casei YIT9018 (LC9018) on a highly metastatic variant of B16 melanoma in C57BL/6J mice. Cancer Immunol. Immunother., 24, 99–105.
Matsuzaki, T., Yokokura, T. and Mutai, M. (1988) Antitumour effect of intrapleural administration of Lactobacillus casei in mice. Cancer Immunol. Immunother., 26, 209–214.
Mehata, A. M., Patel, K. A. and Dave, P. J. (1983) Isolation and purification of an inhibitory protein from Lactobacillus acidophilus AC1. Microbios, 37, 37–43.
Metchnikoff, E. (1908) The Prolongation of Life (Translation by P. C. Michell), C. P. Putnam’s Sons, New York, pp. 161–183.
Montes, R. G., Bayless, T. M., Saavedra, J. M. and Perman, J. A. (1995) Effect of milks inoculated with Lactobacillus acidophilus or a yogurt starter culture in lactose-maldigesting children. J. Dairy Sci., 78, 1657–1664.
Moore, W. E. C. and Moore, L. H. (1995) Intestinal floras of populations that have a high risk of colon cancer. Appl. Environ. Microbiol., 61, 3202–3207.
Morotomi, M. and Mutai, M. (1986) In vitro binding of potent mutagenic pyro-lysates to intestinal bacteria. J. Natl Cancer Inst., 77, 195–201.
Nadathur, S. R., Gould, S. J. and Bakalinsky, A. T. (1994) Antimutagenicity of fermented milk. J. Dairy Sci., 77, 3287–3295.
Nanno, M., Ohwaki, M. and Mutai, M. (1986) Induction by Lactobacillus casei of increase in macrophage colony-forming cells and serum colony-stimulating activity. Jpn J. Cancer Res. (Gann), 77, 703–710.
Nishioka, K., Miyamoto, T., Kataoka, K. and Nakae, T. (1989) Preliminary studies on antimutagenic activities of lactic acid bacteria. Jpn J. Zootech. Sci., 60, 491–494.
Norred, E. P. and Voss, K. A. (1994) Toxicity and role of fumonisins in animal diseases and human esophageal cancer. J. Food Pro., 57, 522–527.
Novick, A. and Szilard, L. (1952) Anti-mutagens. Nature (London), 170, 926–927.
Okawa, T., Kita, M., Arai, T. et al. (1989) Phase II randomized clinical trial of LC9018 concurrently used with radiation in the treatment of carcinoma of uterine cervix: its effect on tumour reduction and histology. Cancer, 64, 1769–1776.
O’Sullivan, M. G., Thornton, G., O’Sullivan, G. C. and Collins, J. K. (1992) Probiotic bacteria: myth or reality? Trends Food Sci. Technol., 3, 309–314.
Owen, R. L. and Jones, A. L. (1974) Epithelial cell specialization within human Peyer’s patches: an ultrastructural study of intestinal lymphoid follicles. Gastroenterology, 66, 189–203.
Owen, R. L., Pierce, N.F., Apple, R. T. and Cray, W. C. Jr (1986) M cell transport of Vibrio cholerae from the intestinal lumen into Peyer’s patches: a mechanism for antigen sampling and for microbial transepithelial migration. J. Infect. Dis., 153,1108–1118.
Perdigon, G., Alvarez, S., Nader de Macias, M. E. et al. (1986a) Lactobacilli administered orally induce release of enzymes from peritoneal macrophages in mice. Milchwissenschaft, 41, 344–348.
Perdigon, G., Nader de Macias, M. E., Alvarez, S. et al. (1986b) Effect of perorally administered lactobacilli on macrophage activation in mice. Infect. Immun., 53, 404–410.
Perdigon, G., Nader de Macias, M. E., Alvarez, S. et al. (1987) Enhancement of immune response in mice fed with Streptococcus thermophilus and Lactobacillus acidophilus. J. Dairy Sci., 70, 919–926.
Popova, P., Guencheva, G., Davidkova, G. et al. (1993) Stimulation effect of Deodan (an oral preparation from Lactobacillus bulgaricus ‘LB51’) on monocytes/macrophages and host resistance to experimental infection. Int. J. Immunopharmac., 15, 25–37.
Reddy, G. V., Shahani, K. M. and Banerjee, M. R. (1973) Inhibitory effect of yogurt on Ehrlich ascites tumour-cell proliferation. J. Natl Cancer Inst., 50, 815–817.
Reddy, G. V., Friend, B. A., Shahani, K. M. and Farmer, R. E. (1983) Antitumour activity of yogurt components. J. Food Pro., 46, 8–11.
Robinson, R. K. (1989) Special yogurts: the potential health benefits. Dairy Ind. Int., 54, 23–25.
Saavedra, J. M. and Perman, J. A. (1989) Current concepts in lactose malabsorption and intolerance. Annu. Rev. Nutr., 9, 475.
Sakamoto, K. and Konishi, K. (1988) Antitumour effect of normal intestinal microflora on Ehrlich ascites tumour. pn J. Cancer Res. (Gann), 79, 109–116.
Savage, D. C. (1995) Ecology of the intestinal microflora, in The International Scientific Forum on ‘Milk, Dairy Products and Intestinal Microflora’ (Lecture 1), Tokyo (Nov. 25, 1995), pp. 8–9.
Savaiano, D. A. and Levitt, M. D. (1987) Milk intolerance and microbe containing dairy foods. J. Dairy Sci., 70, 356–397.
Sekine, K., Toida, T., Saito, M. et al. (1985) A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumour in mice. Cancer Res., 45, 1300–1307.
Sekine, K., Watanabe-sekine, E., Ohta, J. et al. (1994) Induction and activation of tumouricidal cells in vitro and in vivo by the bacterial cell wall of Bifidobacterium infantis. Bifidobacteria Microflora, 13, 65–77.
Shahani. K. M., Friend, B. A. and Bailey, P. J. (1983) Antitumour activity of fermented colostrum and milk. J. Food Prot., 46, 385–386.
Shimizu, T., Nomoto, K., Yokokura, T. and Mutai, M. (1987) Role of colony-stimulating activity in antitumour activity of Lactobacillus casei in mice. J. leukocyte Biol., 42, 204–212.
Silva, M., Jacobus, N. V., Deneke, C. and Gorbach, S. L. (1987) Antimicrobial substance from a human Lactobacillus strain. Antimicrob. Agents Chemother., 31, 1231–1233.
Sugimura, T. (1982) Mutagens, carcinogens, and tumour promoters in our dairy food. Cancer, 49, 1970–1983.
Suzuki, I., Nomura, M. and Morichi. T. (1991) Isolation of lactic acid bacteria which suppress mold growth and antifungal action. Milchwissenschaft, 46, 640–644.
Takahashi, M., Iwata, S., Yamazaki, N. and Fujiwara, H. (1991) Phagocytosis of the lactic acid bacteria by M cells in the rabbit Peyer’s patches. J. Clin. Electron Microscopy, 24, 532–538.
Tanabe, T., Otani, H. and Hosono, A. (1991) Binding of mutagens with cell wall peptidoglycan of Leuconostoc mesenteroides subsp. dextranicum T-180. Milch-wissenschafl, 46, 622–625.
Tanabe, T., Suyama, K. and Hosono, A. (1994) Effect of sodium dodecylsulphate on the binding of Lactococcus lactis subsp. lactis T-80 cells with Trp-P1. 532-8 J. Dairy Res., 61, 311–315.
Thyagaraja, N. and Hosono, A. (1993) Antimutagenicity of lactic acid bacteria from ‘Idly’ against food-related mutagens. J. Food Pro., 56, 1061–1066.
Thyagaraja, N. and Hosono, A. (1994) Binding properties of lactic acid bacteria from ‘Idly’ towards food-borne mutagens. Food and Chem. Toxicol., 32, 805–809.
Toba, T. Yoshioka, E. and Itoh, T. (1991a) Lacticin, a bacteriocin produced by Lactobacillus delbrueckii subsp. lactis. Letters Appl. Microbiol., 12, 43–45.
Toba, T., Yoshioka, E. and Itoh, T. (1991b) Acidophilucin A, a new heat-labile bacteriocin produced by Lactobacillus acidophilus LAPT 1060. Letters Appl. Microbiol., 12, 106–1068.
Tsuyuki, S., Yamazaki, S., Akashiba, H. et al. (1991) Tumour-suppressive effect of a cell wall preparation, WPG, from Bifidobacterium infantis in germfree and flora-bearing mice. Bifidobacteria Microflora, 10, 43–52.
Vincent, J. G., Veomett, R. C. and Riley, R. I. (1959) Antibacterial activity associated with Lactobacillus acidophilus. J. Bacteriol., 78, 477.
Yamaguchi, T., Hoshino, F., Aso, H. et al. (1981) Streptococcus faecalis as bacterial immunostimulant, in Current Chemotherapy and Immunotherapy. Proceedings of 12th International Congress of Chemotherapy, 1175–1177. American Society of Microbiology. Washington, DC.
Yamaguchi, T., Kuroda, Y., Saito, M. et al. (1984) Immune interferon production by TH69, a lyophilized preparation of Streptococcus faecalis, in murine spleen cell culture. Microbiol. Immunol., 28, 601–610.
Yamazaki, S., Machii, K., Tsuyuki, S. et al. (1985) Immunological responses to monoassociated Bifidobacterium longum and their relation to prevention of bacterial invention. Immunology, 56, 43–50.
Yasui, H., Mike, A. and Ohwaki, M. (1989) Immunogenicity of Bifidobacterium breve and change in antibody production in Peyer’s patches after oral administration. J. Dairy Sci., 72, 30–35.
Yasutake, N., Kato, I., Ohwaki, M. et al. (1984) Host-mediated antitumour activity of Lactobacillus casei in mice. Gann, 75, 72–80.
Yukuchi, H., Goto, T. and Okonogi, S. (1992) The nutritional and physiological value of fermented milks and lactic milk drinks, in Functions of Fermented Milk (eds Y. Nakazawa and A. Hosono), Elsevier Applied Science, London, pp. 2–45.
Zbar, B., Bernstein, I. D., Bartlett, G. L. et al. (1972) Immunotherapy of cancer: regression of intradermal tumours and prevention of growth of lymph node métastases after intralesional injection of living Mycobacterium bovis. J. Natl Cancer Inst., 49, 119–130.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Hosono, A., Kitazawa, H., Yamaguchi, T. (1997). Antimutagenic and Antitumour Activities of Lactic Acid Bacteria. In: Fuller, R. (eds) Probiotics 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5860-2_5
Download citation
DOI: https://doi.org/10.1007/978-94-011-5860-2_5
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6476-7
Online ISBN: 978-94-011-5860-2
eBook Packages: Springer Book Archive